Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nordion Inc T.NDN

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s): NDZ

Nordion, Inc., is a health science company that provides products used for the prevention, diagnosis and treatment of disease. The Company mainly provides targeted therapies, sterilization technologies and medical isotopes.
Price: $12.46 | Change: $0.00 | % Change: 0.00%
Volume: 10,030 | Day High/Low: 12.53/12.46 | 52 Week High/Low: 12.84/6.89

View modes: 
5 stars

Sad, Sad

Ooooo, this is ugly! Then again - the writing was on the wall. Shareholders must heed the warnings. Wait, wait - individual shareholders are not to be chastised. We all know that it is the...read more
0 stars

Nordion Shareholder Alert: Former SEC Attorney Willie Brisco

Did anyone contact this law firm?  Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating...read more
0 stars

RE:RE:RE:RE:US$11.75 per share

It's interesting to think that the original name of the OSC was the "Security Frauds Prevention Board". I am no longer a shareholder but for the sake of others, I hope that the OSC has adequate...read more
0 stars

2013 Earnings

Basic earnings listed as $3.83 per share, and that means the P/E ratio is like... 3? Why were the 2013 earnings so sky high?  rate and reply
5 stars

RE:RE:RE:US$11.75 per share

Where the OSC and the government show no signs of slowing this bad deal at least the lawyers have appeared to help shareholders get a better deal...and this one is a stinker.  Did you read the offer? ...read more
5 stars

RE:RE:US$11.75 per share

This is a low initial offer. I think if we make our intentions known, we should get a much better offer. I will vote No  rate and reply
5 stars

RE:RE:RE:US$11.75 per share

There is only one scenario where this price may make any sense.  There was a recent buy of another stagnant Canadian company by a foreign buyer.  It was also sitting on a mountain of cash.  I am...read more
5 stars

RE:RE:US$11.75 per share

This better be a show...you got that right.  11.75 US for a stock that is sitting on $6 a share in cash and has a single digit P/E...Really!!!!  If stockholders settle for this we will all be getting...read more
0 stars

RE:US$11.75 per share

I liked Therock07's $22.00ish buy out figures better, O-well....on with the show.  rate and reply
0 stars

US$11.75 per share

or about cdn$12.925  rate and reply
0 stars

could be b/c Govt is lifting 25% foreign ownership restrict

  rate and reply
0 stars

RE:Great write-up today!

In the write-up it said: Last week, CIBC downgraded Nordion’s stock to “sector underperformer” based on the rally in share price. But they were sure buying a sh@! load.....go figure......  rate and reply
0 stars

IIROC Trade Halt - Nordion Inc.

What could it be??????????? IIROC Trade Halt - Nordion Inc. 15:51 EDT Friday, March 28, 2014 Toronto, Ontario--(Newsfile Corp. - March 28, 2014) - The following issues have been halted by IIROC...read more
0 stars

Great write-up today!

http://www.theglobeandmail.com/globe-investor/investment-ideas/grand-plan-awaits-for-nordion/article17710420/#dashboard/follows/  rate and reply
0 stars

RE:RE:RE:RE:Ongoing strategic review

It's likely that the strategic review will continue for as long as this "cow" can be milked. Maybe another year or two. Look for closure sometime before Oct 2016. Just my humble opinion.  rate and reply
0 stars

RE:RE:RE:RE:RE:Ongoing strategic review

AGM is April 29Th Perhaps a nice denouement by then....  rate and reply
0 stars

RE:RE:RE:RE:Ongoing strategic review

It's obviously not as simple as a special cash distribution . That would have been announced months ago. Rathet, as I have maintained all along, they are seeking a buyer for the remaining three...read more
0 stars

Record Quarter , growth outlook , $6 per share in cash

Nordion reports in U.S. dollars unless otherwise specified Nordion Inc. (TSX:NDN) (NYSE:NDZ), a leading provider of products and services to the global health science market, today reported results...read more
5 stars

RE:RE:RE:Ongoing strategic review

Looks like the ongoing strategic review is still ongoing.  The Q1 report shows a big beat on earnings but not one decision made in the strategic review.  5 months later the strategy is still kick the ...read more
0 stars

Nordion to Release First Quarter Fiscal 2014 Financial Resul

Nordion Inc. (TSX:NDN; NYSE:NDZ), a leading provider of products and services to the global health science market, today announced that the Company is scheduled to report its first quarter fiscal 2014...read more